Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) EBT Margin (2018)

Historic EBT Margin for DiaMedica Therapeutics (DMAC) over the last 1 years, with Q3 2018 value amounting to 266.0%.

  • DiaMedica Therapeutics' EBT Margin changed N/A to 266.0% in Q3 2018 from the same period last year, while for Jun 2019 it was 1798.0%, marking a year-over-year change of. This contributed to the annual value of 71805.88% for FY2024, which is 160941200.0% down from last year.
  • According to the latest figures from Q3 2018, DiaMedica Therapeutics' EBT Margin is 266.0%.
  • DiaMedica Therapeutics' 5-year EBT Margin high stood at 266.0% for Q3 2018, and its period low was 266.0% during Q3 2018.